<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03130140</url>
  </required_header>
  <id_info>
    <org_study_id>2015.511</org_study_id>
    <nct_id>NCT03130140</nct_id>
  </id_info>
  <brief_title>MOSE to Improve the Diagnostic Accuracy During EUS-guided FNA Using a 19-gauge Needle for Solid Lesions</brief_title>
  <official_title>Macroscopic On-site Quality Evaluation of Biopsy Specimens to Improve the Diagnostic Accuracy During EUS-guided FNA Using a 19-gauge Needle for Solid Lesions: a Multicenter Prospective Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <brief_summary>
    <textblock>
      The technique of macroscopic on-site evaluation (MOSE) has recently been advocated for
      estimating the adequacy of a core specimen for histological diagnosis during EUS-FNA using a
      19-gauge needle. How it compares to the conventional technique of tissue acquisition during
      EUS-FNA is uncertain.

      The objective of this study is to evaluate the quantity and quality of tissue, and the
      diagnostic ability of MOSE when compared with the conventional combined histologic-cytologic
      analysis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the quantity and quality of tissue, and the diagnostic ability of MOSE when
      compared with the conventional combined histologic-cytologic analysis in a randomized
      controlled study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 26, 2016</start_date>
  <completion_date type="Actual">September 1, 2018</completion_date>
  <primary_completion_date type="Actual">September 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic yield: Proportion of patients with adequate tissue for diagnosis obtained by EUS FNA</measure>
    <time_frame>4 weeks</time_frame>
    <description>proportion of patients with adequate tissue for diagnosis obtained by EUS FNA</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">244</enrollment>
  <condition>Solid Tumor</condition>
  <arm_group>
    <arm_group_label>Macroscopic on-site evaluation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EUS-FNA perform with a 19-gauge needle with macroscopic on-site evaluation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>EUS-FNA perform with a 19-gauge needle with conventional techniques.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Macroscopic on-site evaluation</intervention_name>
    <description>Macroscopic on-site evaluation: any aspirated material on a glass slide for inspection of the presence of a macroscopic visible core (MVC). Length of MVC will be measured to determine the adequacy of that puncture.</description>
    <arm_group_label>Macroscopic on-site evaluation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Conventional EUS-FNA</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients (aged between 18 and 80 years) referred for EUS-guided tissue
             acquisition for intestinal or extra-intestinal solid lesions more than 2cm in the
             largest diameter would be included.

        Exclusion Criteria:

          -  Patients with coagulopathy, altered anatomy, contraindications for conscious sedation,
             pregnancy and those who cannot provide informed consent would be excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chinese University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>April 19, 2017</study_first_submitted>
  <study_first_submitted_qc>April 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2017</study_first_posted>
  <last_update_submitted>December 4, 2018</last_update_submitted>
  <last_update_submitted_qc>December 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Charing Chong, MD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

